Related Experiment Video
Updated: Aug 8, 2026

Establishment and Characterization of UTI and CAUTI in a Mouse Model
Published on: June 23, 2015
Cinoxacin therapy for urinary tract infections: therapeutic safety and efficacy
Abstract:
We gave cinoxacin to 125 patients with initial and recurrent urinary tract infections to investigate the safety and efficacy of this new antimicrobial agent. Patients ranging in age from 18 to 92 were treated with 500 mg twice daily for nine days. Analysis showed a satisfactory symptomatic response rate of 96% and a bacteriologic cure rate of 92%, with mild side effects observed in 6% of the participants.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection IV: Nursing Management
Urine Studies II: Urine Culture and Sensitivity Test
Inhibitors of Bacterial DNA Synthesis

